• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PCK
Click for more information
0.00% 2.8¢

PAINCHEK LTD - Announcements

Market Cap $50.71M  ! watchlist Created with Sketch. Add to my watchlist

PainChek Ltd is an Australia-based company, which develops pain assessment technologies.... PainChek Ltd is an Australia-based company, which develops pain assessment technologies. The Company's principal activities are development and commercialization of mobile medical device applications that provide pain assessment for individuals that are unable to communicate with their carers. The Company's PainChek Universal is a complete point-of-care solution that combines the existing PainChek Application with the numerical rating scale (NRS). PainChek Application uses artificial intelligence and facial recognition to detect pain in those who cannot self-report. This gives a voice to those who cannot verbalize pain, whilst also driving objectivity and consistency in all assessments. For those who can self-report, PainChek Universal also includes access to the NRS, a standard used to document pain levels amongst these individuals. PainChek Universal also supports pain assessment using both tools at the point of care, for those people whose ability to communicate fluctuates.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
Filters [Clear]
  • Price Sensitive: Yes
PCK Half Yearly Report and AccountsPRICE SENSITIVE27/02/19
PCK Response to ASX Price QueryPRICE SENSITIVE13/02/19
PCK Quarterly UpdatePRICE SENSITIVE29/01/19
PCK Appendix 4C - quarterlyPRICE SENSITIVE29/01/19
PCK Quarterly UpdatePRICE SENSITIVE15/10/18
PCK Appendix 4C - quarterlyPRICE SENSITIVE15/10/18
PCK Agreement with Leecare SolutionsPRICE SENSITIVE03/10/18
PCK Allity Aged Care partners with PainChekPRICE SENSITIVE10/09/18
PCK Preliminary Final ReportPRICE SENSITIVE27/08/18
PCK Investor UpdatePRICE SENSITIVE31/07/18
PCK Appendix 4C - quarterlyPRICE SENSITIVE31/07/18
PCK National roll out with DSA follows successful pilotPRICE SENSITIVE14/06/18 download Created with Sketch. 289.82KB
PCK New publication confirms accuracy of PainChek(R)PRICE SENSITIVE07/06/18 download Created with Sketch. 297.6KB
PCK PainChek receives FDA regulatory guidancePRICE SENSITIVE09/05/18
PCK Quarterly Update and Appendix 4CPRICE SENSITIVE24/04/18
PCK Agreement signed with leading software system providerPRICE SENSITIVE27/03/18
PCK Half Year Report and Financial StatementsPRICE SENSITIVE23/02/18
PCK Quarterly Update and Appendix 4CPRICE SENSITIVE30/01/18
PCK PainChek App Android version now in beta testingPRICE SENSITIVE30/01/18
PCK New Peer reviewed published studyPRICE SENSITIVE29/01/18
PCK 2nd peer-review confirms excellent performance of PainChekPRICE SENSITIVE13/12/17
PCK ePAT and PainChek continue to achieve commercial milestonesPRICE SENSITIVE08/11/17
PCK Quarterly Update and Appendix 4CPRICE SENSITIVE31/10/17
PCK Placement to raise $3.75 millionPRICE SENSITIVE18/09/17
PCK Trading HaltPRICE SENSITIVE14/09/17
PCK Core strategic agreement with Dementia Support AustraliaPRICE SENSITIVE07/09/17
PCK Preliminary Final ReportPRICE SENSITIVE29/08/17
PCK ePAT Clinical Study Published in Alzheimer's Disease JournalPRICE SENSITIVE15/08/17
PCK Response to ASX Price QueryPRICE SENSITIVE14/08/17
PCK Quarterly Update and Appendix 4CPRICE SENSITIVE31/07/17
PCK nViso agrees perpetual global license, takes strategic stakePRICE SENSITIVE24/07/17
PCK Response to ASX queryPRICE SENSITIVE24/07/17
PCK ePAT Pain Assessment App Secures Regulatory ClearancePRICE SENSITIVE19/07/17
PCK New Study Validates Face Recognition App in Pain DetectionPRICE SENSITIVE04/07/17
PCK Appendix 4C - quarterlyPRICE SENSITIVE28/04/17
PCK Launch of IBM Case StudyPRICE SENSITIVE15/03/17
PCK Half Yearly Report and AccountsPRICE SENSITIVE22/02/17
PCK Second Quarter Report FY 2016/17PRICE SENSITIVE30/01/17
PCK Appendix 4C - quarterlyPRICE SENSITIVE30/01/17
PCK Market UpdatePRICE SENSITIVE14/12/16
PCK Market Update-EPT.AX PRICE SENSITIVE02/11/16
PCK Quarterly Review and Appendix 4C-EPT.AX PRICE SENSITIVE31/10/16
PCK Reinstatement to Official List - 19/10/2016-EPT.AX PRICE SENSITIVE18/10/16
PCK Half Yearly Report and Accounts
27/02/19PRICE SENSITIVE
PCK Response to ASX Price Query
13/02/19PRICE SENSITIVE
PCK Quarterly Update
29/01/19PRICE SENSITIVE
PCK Appendix 4C - quarterly
29/01/19PRICE SENSITIVE
PCK Quarterly Update
15/10/18PRICE SENSITIVE
PCK Appendix 4C - quarterly
15/10/18PRICE SENSITIVE
PCK Agreement with Leecare Solutions
03/10/18PRICE SENSITIVE
PCK Allity Aged Care partners with PainChek
10/09/18PRICE SENSITIVE
PCK Preliminary Final Report
27/08/18PRICE SENSITIVE
PCK Investor Update
31/07/18PRICE SENSITIVE
PCK Appendix 4C - quarterly
31/07/18PRICE SENSITIVE
PCK National roll out with DSA follows successful pilot
14/06/18PRICE SENSITIVE download Created with Sketch. 289.82KB
PCK New publication confirms accuracy of PainChek(R)
07/06/18PRICE SENSITIVE download Created with Sketch. 297.6KB
PCK PainChek receives FDA regulatory guidance
09/05/18PRICE SENSITIVE
PCK Quarterly Update and Appendix 4C
24/04/18PRICE SENSITIVE
PCK Agreement signed with leading software system provider
27/03/18PRICE SENSITIVE
PCK Half Year Report and Financial Statements
23/02/18PRICE SENSITIVE
PCK Quarterly Update and Appendix 4C
30/01/18PRICE SENSITIVE
PCK PainChek App Android version now in beta testing
30/01/18PRICE SENSITIVE
PCK New Peer reviewed published study
29/01/18PRICE SENSITIVE
PCK 2nd peer-review confirms excellent performance of PainChek
13/12/17PRICE SENSITIVE
PCK ePAT and PainChek continue to achieve commercial milestones
08/11/17PRICE SENSITIVE
PCK Quarterly Update and Appendix 4C
31/10/17PRICE SENSITIVE
PCK Placement to raise $3.75 million
18/09/17PRICE SENSITIVE
PCK Trading Halt
14/09/17PRICE SENSITIVE
PCK Core strategic agreement with Dementia Support Australia
07/09/17PRICE SENSITIVE
PCK Preliminary Final Report
29/08/17PRICE SENSITIVE
PCK ePAT Clinical Study Published in Alzheimer's Disease Journal
15/08/17PRICE SENSITIVE
PCK Response to ASX Price Query
14/08/17PRICE SENSITIVE
PCK Quarterly Update and Appendix 4C
31/07/17PRICE SENSITIVE
PCK nViso agrees perpetual global license, takes strategic stake
24/07/17PRICE SENSITIVE
PCK Response to ASX query
24/07/17PRICE SENSITIVE
PCK ePAT Pain Assessment App Secures Regulatory Clearance
19/07/17PRICE SENSITIVE
PCK New Study Validates Face Recognition App in Pain Detection
04/07/17PRICE SENSITIVE
PCK Appendix 4C - quarterly
28/04/17PRICE SENSITIVE
PCK Launch of IBM Case Study
15/03/17PRICE SENSITIVE
PCK Half Yearly Report and Accounts
22/02/17PRICE SENSITIVE
PCK Second Quarter Report FY 2016/17
30/01/17PRICE SENSITIVE
PCK Appendix 4C - quarterly
30/01/17PRICE SENSITIVE
PCK Market Update
14/12/16PRICE SENSITIVE
PCK Market Update-EPT.AX
02/11/16PRICE SENSITIVE
PCK Quarterly Review and Appendix 4C-EPT.AX
31/10/16PRICE SENSITIVE
PCK Reinstatement to Official List - 19/10/2016-EPT.AX
18/10/16PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
2.8¢ 		Change
0.000(0.00%) 		Mkt cap ! $50.71M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
2 99999 3.0¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 60000 1
View Market Depth
Last trade - 07.10am 22/11/2024 (20 minute delay) ?
PCK (ASX) Chart

Top Stories

To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels

Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Sales growth pushes Lovisa's fortunes (and shares) upwards Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and on a good day for the consumer discretionary sector
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.